Injectables

Oral (tablets)

Libido

Peptides

Injection Ampoules

Injection Vials

Tablets

Orals

Weight loss, fat burning

Concentração

Concentración

Concentration

Concentrazione

Konzentration

Objętość

Stężenie

Volume

Volumen

MOTS-c is a unique mitochondrial-derived peptide (MDP) encoded within the Mitochondrial ORF of the 12S rRNA. It plays a crucial role in cellular energy regulation, metabolic balance, and stress response. By enhancing insulin sensitivity, promoting glucose utilization, and improving mitochondrial function, MOTS-c is an exciting peptide for research into metabolic disorders, exercise performance, and longevity.

Why MOTS-c Stands Out

Unlike traditional peptides that originate from nuclear DNA, MOTS-c is encoded in mitochondrial DNA, linking it directly to energy production and cellular homeostasis. Research suggests it may help combat age-related metabolic decline, obesity, and insulin resistance:

    Metabolic Regulation: Enhances glucose uptake and utilization
    Mitochondrial Function: Supports energy production and stress adaptation
    Longevity Potential: May contribute to healthy aging and metabolic resilience

Key Benefits of MOTS-c

    ✅ Improves insulin sensitivity & glucose metabolism
    ✅ Supports weight management and fat oxidation
    ✅ Enhances cellular energy production
    ✅ Promotes exercise endurance and recovery
    ✅ Potential role in healthy aging and longevity research

Application & Dosage Guidelines

    Dosage Range (Research Use): 5 mg to 10 mg per week (varies by study)
    Administration: Subcutaneous injection (research use only)
    Frequency: 2–3 times per week (study dependent)
    Reconstitution: Mix with bacteriostatic or sterile water for injection
    Storage: Keep refrigerated after mixing (up to 10 days)

⚠️ Safety & Side Effects

All dosing information is for research purposes only and not for human consumption unless prescribed by a licensed medical professional. Possible dose-dependent effects may include:

    Temporary fatigue or mild nausea
    Hormonal or metabolic fluctuations
    Rare digestive discomfort

Preclinical and clinical studies suggest MOTS-c may be a promising therapeutic candidate for type 2 diabetes, obesity, and age-related metabolic decline.

MOTS-c (10mg)